Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer
Clinical trial NCT02216669 · WITHDRAWN
Trial details
- NCT number
- NCT02216669
- Sponsor
- Maastricht Radiation Oncology
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2017-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.